Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom

Fig. 3

Correlation between 6-TGN concentration and clinical response rate within 12 months. No significant difference was found between the four quartiles (p = 0.47, Pearson Chi Square). At a cut-off level of 771 pmol/8 × 105 RBC no significant difference was found below and above the cut-off level (P = 0.09, T-test)

Back to article page